Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion evidence source_evidence_literature NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion SIO_000772 24079759 NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion wasDerivedFrom befree-20150227 NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_assertion wasGeneratedBy ECO_0000203 NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP779869.RA_X7V2BpTUTH0F-NVaO4nEryRhHnbVe15PHrW7e1Q07Q130_provenance.